Literature DB >> 20222112

Regulation of CCN2/connective tissue growth factor expression in the nucleus pulposus of the intervertebral disc: role of Smad and activator protein 1 signaling.

Cassie M Tran1, Dessislava Markova, Harvey E Smith, Bala Susarla, Ravi Kumar Ponnappan, D Greg Anderson, Aviva Symes, Irving M Shapiro, Makarand V Risbud.   

Abstract

OBJECTIVE: To investigate transforming growth factor beta (TGFbeta) regulation of connective tissue growth factor (CTGF) expression in cells of the nucleus pulposus of rats, mice, and humans.
METHODS: Real-time reverse transcription-polymerase chain reaction and Western blot analyses were used to measure CTGF expression in the nucleus pulposus. Transfections were used to measure the effects of Smads 2, 3, and 7 and activator protein 1 (AP-1) on TGFbeta-mediated CTGF promoter activity.
RESULTS: CTGF expression was lower in neonatal rat discs than in skeletally mature rat discs. An increase in CTGF expression and promoter activity was observed in rat nucleus pulposus cells after TGFbeta treatment. Deletion analysis indicated that promoter constructs lacking Smad and AP-1 motifs were unresponsive to treatment. Analysis showed that full-length Smad3 and the Smad3 MH-2 domain alone increased CTGF activity. Further evidence of Smad3 and AP-1 involvement was seen when DN-Smad3, SiRNA-Smad3, Smad7, and DN-AP-1 suppressed TGFbeta-mediated activation of the CTGF promoter. When either Smad3 or AP-1 sites were mutated, CTGF promoter induction by TGFbeta was suppressed. We also observed a decrease in the expression of CTGF in discs from Smad3-null mice as compared with those from wild-type mice. Analysis of human nucleus pulposus samples indicated a trend toward increasing CTGF and TGFbeta expression in the degenerated state.
CONCLUSION: TGFbeta, through Smad3 and AP-1, serves as a positive regulator of CTGF expression in the nucleus pulposus. We propose that CTGF is a part of the limited reparative response of the degenerated disc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20222112      PMCID: PMC3060556          DOI: 10.1002/art.27445

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  36 in total

Review 1.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 2.  Extracellular matrix in disc degeneration.

Authors:  Haoyu Feng; Mikael Danfelter; Björn Strömqvist; Dick Heinegård
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

3.  Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts.

Authors:  K-H Hong; S-A Yoo; S-S Kang; J-J Choi; W-U Kim; C-S Cho
Journal:  Clin Exp Immunol       Date:  2006-11       Impact factor: 4.330

4.  Nucleus pulposus cells express HIF-1 alpha under normoxic culture conditions: a metabolic adaptation to the intervertebral disc microenvironment.

Authors:  Makarand V Risbud; Asha Guttapalli; David G Stokes; David Hawkins; Keith G Danielson; Thomas P Schaer; Todd J Albert; Irving M Shapiro
Journal:  J Cell Biochem       Date:  2006-05-01       Impact factor: 4.429

5.  Hypoxic induction of Ctgf is directly mediated by Hif-1.

Authors:  Debra F Higgins; Mangatt P Biju; Yasuhiro Akai; Anton Wutz; Randall S Johnson; Volker H Haase
Journal:  Am J Physiol Renal Physiol       Date:  2004-08-17

6.  Transforming growth factor-beta2 upregulates sphingosine kinase-1 activity, which in turn attenuates the fibrotic response to TGF-beta2 by impeding CTGF expression.

Authors:  Shuyu Ren; Andrea Babelova; Kristin Moreth; Cuiyan Xin; Wolfgang Eberhardt; Anke Doller; Hermann Pavenstädt; Liliana Schaefer; Josef Pfeilschifter; Andrea Huwiler
Journal:  Kidney Int       Date:  2009-08-05       Impact factor: 10.612

7.  Inhibition of connective tissue growth factor (CTGF/CCN2) expression decreases the survival and myogenic differentiation of human rhabdomyosarcoma cells.

Authors:  Stefania Croci; Lorena Landuzzi; Annalisa Astolfi; Giordano Nicoletti; Angelo Rosolen; Francesca Sartori; Matilde Y Follo; Noelynn Oliver; Carla De Giovanni; Patrizia Nanni; Pier-Luigi Lollini
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

Review 8.  Functions and mechanisms of action of CCN matricellular proteins.

Authors:  Chih-Chiun Chen; Lester F Lau
Journal:  Int J Biochem Cell Biol       Date:  2008-08-15       Impact factor: 5.085

9.  Human connective tissue growth factor expressed in Escherichia coli is a non-mitogenic inhibitor of apoptosis.

Authors:  Daniel Gygi; Peter Zumstein; Doris Grossenbacher; Lukas Altwegg; Thomas F Lüscher; Heinz Gehring
Journal:  Biochem Biophys Res Commun       Date:  2003-11-21       Impact factor: 3.575

10.  The Notochord, Notochordal cell and CTGF/CCN-2: ongoing activity from development through maturation.

Authors:  W Mark Erwin
Journal:  J Cell Commun Signal       Date:  2008-11-12       Impact factor: 5.782

View more
  36 in total

1.  Transforming growth factor β controls CCN3 expression in nucleus pulposus cells of the intervertebral disc.

Authors:  Cassie M Tran; Harvey E Smith; Aviva Symes; Laure Rittié; Bernard Perbal; Irving M Shapiro; Makarand V Risbud
Journal:  Arthritis Rheum       Date:  2011-10

2.  p16Ink4a deletion in cells of the intervertebral disc affects their matrix homeostasis and senescence associated secretory phenotype without altering onset of senescence.

Authors:  Emanuel J Novais; Brian O Diekman; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2019-02-24       Impact factor: 11.583

3.  Connective tissue and its growth factor CTGF distinguish the morphometric and molecular remodeling of the bladder in a model of neurogenic bladder.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Kenan Izgi; Fuat Bicer; Ahmet Ozer; Cagri Sakalar; Kerry O Grimberg; Ismail Sayin; Vincent K Tuohy
Journal:  Am J Physiol Renal Physiol       Date:  2012-09-19

4.  Developments in intervertebral disc disease research: pathophysiology, mechanobiology, and therapeutics.

Authors:  Kathryn T Weber; Timothy D Jacobsen; Robert Maidhof; Justin Virojanapa; Chris Overby; Ona Bloom; Shaheda Quraishi; Mitchell Levine; Nadeen O Chahine
Journal:  Curr Rev Musculoskelet Med       Date:  2015-03

Review 5.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

6.  Hypoxia-inducible factor (HIF)-1α and CCN2 form a regulatory circuit in hypoxic nucleus pulposus cells: CCN2 suppresses HIF-1α level and transcriptional activity.

Authors:  Cassie M Tran; Nobuyuki Fujita; Bau-Lin Huang; Jessica R Ong; Karen M Lyons; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2013-03-24       Impact factor: 5.157

7.  CCN2 suppresses catabolic effects of interleukin-1β through α5β1 and αVβ3 integrins in nucleus pulposus cells: implications in intervertebral disc degeneration.

Authors:  Cassie M Tran; Zachary R Schoepflin; Dessislava Z Markova; Christopher K Kepler; D Greg Anderson; Irving M Shapiro; Makarand V Risbud
Journal:  J Biol Chem       Date:  2014-01-24       Impact factor: 5.157

8.  Degenerative grade affects the responses of human nucleus pulposus cells to link-N, CTGF, and TGFβ3.

Authors:  Rosalyn D Abbott; Devina Purmessur; Robert D Monsey; David R Brigstock; Damien M Laudier; James C Iatridis
Journal:  J Spinal Disord Tech       Date:  2013-05

9.  TGFβ regulates Galectin-3 expression through canonical Smad3 signaling pathway in nucleus pulposus cells: implications in intervertebral disc degeneration.

Authors:  Ye Tian; Wen Yuan; Jun Li; Hua Wang; Maxwell G Hunt; Chao Liu; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2015-11-27       Impact factor: 11.583

Review 10.  Molecular regulation of CCN2 in the intervertebral disc: lessons learned from other connective tissues.

Authors:  Cassie M Tran; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2013-04-06       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.